Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$768,648,782
+$188,771,508 QoQ
Shares Held
640,845
+1.6% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#108
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $3,027,251,343 across 9 Drug Manufacturers - General names. LLY ranks #1 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
640,845 | $768,648,782 | |
| 2 | JNJ |
Johnson & Johnson
|
2,438,843 | $619,392,956 | |
| 3 | ABBV |
AbbVie Inc.
|
1,761,265 | $443,204,724 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,816,256 | $361,888,896 | |
| 5 | AZN |
Astrazeneca PLC
|
1,526,363 | $289,428,952 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,648,030 | $208,212,110 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,765,830 | $159,367,124 | |
| 8 | PFE |
Pfizer Inc
|
6,258,004 | $150,692,736 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $768,648,782 | 640,845 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $579,877,274 | 630,459 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $673,680,415 | 626,866 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $623,242,053 | 816,831 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $602,317,105 | 772,667 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $631,701,392 | 764,855 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $581,651,048 | 753,434 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $696,137,985 | 785,762 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $695,143,520 | 767,792 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $559,181,309 | 718,779 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $412,547,056 | 707,725 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $389,959,063 | 726,005 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $338,851,649 | 722,529 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $200,244,766 | 583,090 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $209,900,333 | 573,749 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $201,845,740 | 624,233 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $204,277,220 | 630,038 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $218,837,080 | 764,176 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $213,949,791 | 774,563 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $183,057,217 | 792,284 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $181,085,771 | 788,976 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $147,078,154 | 787,272 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $137,594,638 | 814,941 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $111,896,606 | 755,956 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $123,632,299 | 753,029 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $104,071,072 | 750,224 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||